Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
Authors
Keywords
-
Journal
Pharmaceutics
Volume 13, Issue 9, Pages 1491
Publisher
MDPI AG
Online
2021-09-18
DOI
10.3390/pharmaceutics13091491
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and Tolerability of Topical Ophthalmic Triamcinolone Acetonide-Loaded Liposomes Formulation and Evaluation of Its Biologic Activity in Patients with Diabetic Macular Edema
- (2021) Jose Navarro-Partida et al. Pharmaceutics
- Topical Triamcinolone Acetonide-Loaded Liposomes as Primary Therapy for Macular Edema Secondary to Branch Retinal Vein Occlusion: A Pilot Study
- (2020) Jose Navarro-Partida et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study
- (2019) Alejandro Gonzalez-De la Rosa et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- A more efficient ocular delivery system of triamcinolone acetonide as eye drop to the posterior segment of the eye
- (2019) Jin Li et al. DRUG DELIVERY
- The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2019) Peter A. Campochiaro et al. OPHTHALMOLOGY
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
- (2019) Pravin U. Dugel et al. OPHTHALMOLOGY
- Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery
- (2018) Juan C. Altamirano-Vallejo et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- 2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations
- (2018) Andrzej Grzybowski et al. OPHTHALMOLOGICA
- TWO YEAR OUTCOMES OF “TREAT AND EXTEND” INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2018) Daniel Barthelmes et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases
- (2017) Rohit Bisht et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration
- (2016) Marion R. Munk et al. ACTA OPHTHALMOLOGICA
- Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye
- (2016) Joana F. Fangueiro et al. CURRENT PHARMACEUTICAL DESIGN
- PROGRESSION OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
- (2016) Nizar Saleh Abdelfattah et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Epidemiological and Clinical Baseline Characteristics as Predictive Biomarkers of Response to Anti-VEGF Treatment in Patients with Neovascular AMD
- (2016) Miltiadis K. Tsilimbaris et al. Journal of Ophthalmology
- Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases
- (2016) I. Bravo-Osuna et al. Drug Delivery and Translational Research
- Ocular Pharmacokinetics of Fluocinolone Acetonide Following Iluvien Implantation in the Vitreous Humor of Rabbits
- (2015) Frances E. Kane et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration
- (2015) Charles C. Wykoff et al. OPHTHALMOLOGY
- Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration
- (2015) Mark C. Gillies et al. OPHTHALMOLOGY
- Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach
- (2015) Chiara B. M. Platania et al. Frontiers in Pharmacology
- Mechanism of Mucosal Permeability Enhancement of CriticalSorb® (Solutol® HS15) Investigated In Vitro in Cell Cultures
- (2014) Saif Shubber et al. PHARMACEUTICAL RESEARCH
- Intravitreal Steroids for the Treatment of Retinal Diseases
- (2014) Valentina Sarao et al. TheScientificWorldJOURNAL
- Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
- (2014) Wan Ling Wong et al. Lancet Global Health
- Implantable MicroPump for Drug Delivery in Patients with Diabetic Macular Edema
- (2014) Mark Humayun et al. Translational Vision Science & Technology
- Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
- (2013) K Ghasemi Falavarjani et al. EYE
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
- (2013) Usha Chakravarthy et al. LANCET
- Drug Delivery Implants in the Treatment of Vitreous Inflammation
- (2013) Jillian Wang et al. MEDIATORS OF INFLAMMATION
- Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors and outcomes
- (2012) D A M Lyall et al. EYE
- Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life
- (2012) Katharina M. Droege et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema
- (2012) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Aqueous Levels of Fluocinolone Acetonide after Administration of Fluocinolone Acetonide Inserts or Fluocinolone Acetonide Implants
- (2012) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Drug safety evaluation of intravitreal triamcinolone acetonide
- (2011) Daniele Veritti et al. Expert Opinion On Drug Safety
- Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study
- (2011) Frank G. Holz et al. OPHTHALMOLOGY
- Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: A 3-Year Multicenter, Randomized, Controlled Clinical Trial
- (2011) P. Andrew Pearson et al. OPHTHALMOLOGY
- INTRAVITREAL BEVACIZUMAB VERSUS COMBINED INTRAVITREAL BEVACIZUMAB AND TRIAMCINOLONE FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2011) Hamid Ahmadieh et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- PHARMACOKINETIC RATIONALE FOR DOSING EVERY 2 WEEKS VERSUS 4 WEEKS WITH INTRAVITREAL RANIBIZUMAB, BEVACIZUMAB, AND AFLIBERCEPT (VASCULAR ENDOTHELIAL GROWTH FACTOR TRAP-EYE)
- (2011) Michael W. Stewart et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections
- (2010) Carsten H. Meyer et al. ACTA OPHTHALMOLOGICA
- Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration
- (2010) Leila el Matri et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Intravitreal Bevacizumab Combined With Intravitreal Triamcinolone for Therapy-Resistant Exudative Age-Related Macular Degeneration
- (2010) Yong Tao et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration
- (2009) Jost B. Jonas et al. ACTA OPHTHALMOLOGICA
- A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
- (2009) Geeta A. Lalwani et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
- (2009) P Mitchell et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Recent Perspectives in Ocular Drug Delivery
- (2009) Ripal Gaudana et al. PHARMACEUTICAL RESEARCH
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
- (2008) Carl D. Regillo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Intravitreal Bevacizumab and Triamcinolone Acetonide Combination Therapy for Exudative Neovascular Age-Related Macular Degeneration: Short-Term Optical Coherence Tomography Results
- (2008) Michael Colucciello JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Intraocular Concentration of Triamcinolone Acetonide after Intravitreal Injection in the Rabbit Eye
- (2008) Bernd A. Kamppeter et al. OPHTHALMOLOGY
- INTRAVITREAL TRIAMCINOLONE FOR DIABETIC MACULAR EDEMA
- (2008) DAVID HAUSER et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started